HF
BLTE

HRT Financial’s Belite Bio BLTE Stock Holding History

HRT Financial’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74M Buy
10,922
+2,758
+34% +$464K ﹤0.01% 1706
2025
Q4 		$1.3M Buy
+8,164
New +$967K ﹤0.01% 1562
2025
Q2 		– Sell
-4,117
Closed -$272K – 2642
2025
Q1 		$272K Buy
+4,117
New +$248K ﹤0.01% 1827
2024
Q3 		– Sell
-5,409
Closed -$247K – 2445
2024
Q2 		$247K Buy
+5,409
New +$234K ﹤0.01% 1580

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HRT Financial's BLTE Position: Q1 2026 in Review

HRT Financial increased its Belite Bio (BLTE) stake by 34% in Q1 2026, buying an estimated $464K and bringing the position to 10,922 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1706.

HRT Financial first reported a position in BLTE in Q2 2024 and has held it in 4 quarters since. 75 funds tracked by Wall St. Rank hold BLTE as of Q1 2026.

  • HRT Financial held 10,922 shares of Belite Bio worth $1.74M as of Q1 2026.
  • HRT Financial bought 2,758 Belite Bio shares in Q1 2026, an estimated $464K.
  • Belite Bio made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #1706 holding.
  • HRT Financial first reported a position in Belite Bio in Q2 2024 and has held it in 4 quarters since.
  • 75 funds tracked by Wall St. Rank held Belite Bio as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.